Frequency ExchangeFRECF 8 Net Cash per Share is $0.00 as of Mar. 2026. GuruFocus rates FRECF with a GF Score™ of 8/100 and a GF Value™ of $0.08 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 303 Medical Devices & Instruments companies, Frequency Exchange ranks worse than 330032.67% on this metric.
The historical rank and industry rank for Frequency Exchange's Net Cash per Share or its related term are showing as below:
During the past 6 years, the highest Price-to-Net-Cash Ratio of Frequency Exchange was 28.50. The lowest was 3.17. And the median was 8.63.
FRECF's Price-to-Net-Cash is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 8 * Ranked among companies with meaningful Price-to-Net-Cash only.
Frequency Exchange (OTCPK:FRECF) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Frequency Exchange Net Cash per Share Related Terms
Frequency Exchange Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Frequency Exchange's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRECF vs ABT, SYK, MDT: Net Cash per Share Comparison
For the Medical Devices subindustry, Frequency Exchange's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frequency Exchange Price-to-Net-Cash vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Frequency Exchange's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Frequency Exchange's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Frequency Exchange's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frequency Exchange (FRECF) has a Net Cash per Share of $0.00 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Frequency Exchange and its competitors. Over the past decade, Frequency Exchange's Net Cash per Share has ranged from 3.17 to 28.50. According to the industry distribution chart, Frequency Exchange ranks #999999 out of 303 companies in the Medical Devices & Instruments industry.
Is Frequency Exchange's Net Cash per Share too high?
Frequency Exchange's current Net Cash per Share is $0.00. Over the past 10 years, this metric has ranged from a low of 3.17 to a high of 28.50. Based on the distribution chart, Frequency Exchange ranks #999999 out of 303 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Frequency Exchange has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Frequency Exchange's Net Cash per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Frequency Exchange ranks #999999 out of 303 companies for Net Cash per Share. This places Frequency Exchange in the lower half of its industry. The industry median Net Cash per Share is 8.00. Historically, Frequency Exchange's own Net Cash per Share has ranged from 3.17 to 28.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Medical Devices & Instruments company?
The median Net Cash per Share among Medical Devices & Instruments companies is 8.00, based on 303 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Frequency Exchange and its competitors. For the Medical Devices & Instruments industry, the median Net Cash per Share is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frequency Exchange's current Net Cash per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frequency Exchange stock overvalued right now?
Based on GuruFocus' analysis, Frequency Exchange (FRECF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.08, compared to a current price of $0.24 — trading 202.8% above its estimated fair value. The current Net Cash per Share is $0.00. Frequency Exchange's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Frequency Exchange (FRECF), the current Net Cash per Share is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frequency Exchange (FRECF) Overvalued in 2026?
Based on GuruFocus' analysis, Frequency Exchange stock appears to be overvalued.
The current stock price of $0.24 is trading 202.8% above its estimated GF Value™ of $0.08.
GuruFocus considers Frequency Exchange to be Significantly Overvalued.
Key valuation signals for FRECF:
Net Cash per Share: $0.00
GF Value™: $0.08 vs. price of $0.24 (202.8% above fair value)
No single metric tells the full story. See the FRECF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frequency Exchange Corp is focused on the development and world-wide commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement. The company has one operating and reportable segment which the sale of wearable devices. Geographically, it operates in Canada; United States; and International.
8GF Score
Get the complete analysis for FRECF
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRECF has been successfully added to your 
